Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus
Open Access
- 28 January 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
The role of epigenetic modifications on the carcinogenesis process has received a lot of attention in the last years. Among those, histone acetylation is a process regulated by histone deacetylases (HDAC) and histone acetyltransferases (HAT), and it plays an important role in epigenetic regulation, allowing the control of the gene expression. HDAC inhibitors (HDACi) induce cancer cell cycle arrest, differentiation, and cell death and reduce angiogenesis and other cellular events. Human papillomaviruses (HPVs) are small, non-enveloped double-stranded DNA viruses. They are major human carcinogens, being intricately linked to the development of cancer in 4.5% of the patients diagnosed with cancer worldwide. Long-term infection of high-risk (HR) HPV types, mainly HPV16 and HPV18, is one of the major risk factors responsible for promoting cervical cancer development. In vitro and in vivo assays have demonstrated that HDACi could be a promising therapy to HPV-related cervical cancer. Regardless of some controversial studies, the therapy with HDACi could target several cellular targets which HR-HPV oncoproteins could be able to deregulate. This review article describes the role of HDACi as a possible intervention in cervical cancer treatment induced by HPV, highlighting the main advances reached in the last years and providing insights for further investigations regarding those agents against cervical cancer.Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 194 references indexed in Scilit:
- Bortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cellsPharmacological Research, 2013
- A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancerProceedings of the National Academy of Sciences of the United States of America, 2012
- Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylasesCarcinogenesis: Integrative Cancer Research, 2011
- Inhibitors of Histone DeacetylasesOnline Journal of Public Health Informatics, 2011
- Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical DiseaseThe Journal of Infectious Diseases, 2011
- Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studiesBioorganic & Medicinal Chemistry, 2009
- A review of human carcinogens—Part B: biological agentsPublished by Elsevier BV ,2009
- Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?British Journal of Cancer, 2008
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and menNature Reviews Molecular Cell Biology, 2008
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006